QIAGEN N.V. Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount
QIAGEN N.V. (QGEN) reported Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount of $0 for the 12-month period ending 2020-12-31, per its 20-F filed 2021-03-05.
Discontinued › Notes › Investments › Debt and Equity Securities › Equity Securities without Readily Determinable Fair Value, Annual Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount · last filed 2021-03-05
| Period end | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 12 month | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 24 month |
|---|---|---|
| 2020-12-31 | $0.00 20-F · filed 2021-03-05 | |
| 2019-12-31 | $7.76M 20-F · filed 2021-03-05 | $20.90M 20-F · filed 2020-03-02 |
| 2018-12-31 | $13.10M 20-F · filed 2020-03-02 | |
| 2017-12-31 | $0.00 20-F · filed 2019-03-06 |